Nu-Med Plus, Inc.

What they do

Nu-Med Plus was incorporated in October 2011 to develop, manufacture and market technologies using nitric oxide in the medical device field, primarily a nitric oxide generating compound formulation and delivery systems. The company states it has developed a hospital nitric oxide delivery system, a clinical nitric oxide delivery system, a mobile rechargeable device to deliver nitric oxide gas, and a nitric oxide system for research applications. On June 26, 2026, the company entered a Mineral Property Purchase Agreement to acquire six gold mineral properties in Nova Scotia, New Brunswick, and Newfoundland and Labrador. The 10-Q describes Nu-Med as an early-stage company with no revenue.

Revenue drivers

• Nitric oxide medical device systems — Hospital, clinical, mobile rechargeable, and research nitric oxide delivery systems described as developed, but XBRL annual revenue is $0.00 for 2016 through 2020 and quarterly revenue is $0.00 for the quarters ended 2025-03-31, 2025-06-30, 2026-03-31 and 2026-06-30.
• Gold mineral properties (proposed) — A June 26, 2026 Mineral Property Purchase Agreement covers six gold mineral properties in Nova Scotia, New Brunswick, and Newfoundland and Labrador; no production or revenue from these properties is reported in the financial data provided.

Recent performance

No revenue was reported in any quarter shown: $0.00 for the quarters ended 2025-03-31, 2025-06-30, 2026-03-31 and 2026-06-30. Annual net losses narrowed over the five years shown, from $-830,061 in 2021 to $-130,167 in 2022, $-125,526 in 2023, $-68,345 in 2024 and $-56,182 in 2025. Operating cash flow was negative in each of those years, ranging from $-206,831 in 2021 to $-4,433 in 2024 and $-47,979 in 2025. At June 30, 2026 the balance sheet showed total assets of $12,909, total liabilities of $280,395, shareholders' equity of $-267,486, cash and equivalents of $5,409, and no long-term debt.

Strategy

The company's stated purpose remains developing, manufacturing and marketing nitric oxide medical device technologies, including a hospital delivery system, a clinical delivery system, a mobile rechargeable gas delivery device, and a research system. However, in June 2026 it signed a Mineral Property Purchase Agreement to acquire six gold properties in Nova Scotia, New Brunswick, and Newfoundland and Labrador. Since the last 10-K the company has filed 8-Ks reporting material agreements, acquisitions or dispositions, unregistered equity sales, changes in control, director or officer changes, and amended charter or bylaws in June, July and August 2026. The company qualifies as an emerging growth company and a smaller reporting company and states it intends to remain both for the foreseeable future and to take advantage of reduced disclosure obligations.

Risks

• No revenue — The company reported $0.00 revenue in every annual period from 2016 to 2020 and in each recent quarter shown, and its 10-Q describes it as an early-stage company with no revenue.
• Negative equity and thin cash — At June 30, 2026 shareholders' equity was $-267,486 and cash and equivalents were $5,409 against total liabilities of $280,395.
• Recurring losses and cash burn — Net losses were recorded every year from 2021 to 2025 and operating cash flow was negative in each of those years, including $-47,979 in 2025.
• Business pivot and control changes — The June 2026 gold property agreement and 8-K items regarding acquisitions or dispositions, changes in control, director or officer changes, and amended charter or bylaws indicate substantial changes in the business and governance.

Outlook

Management's 10-Q points readers to Note 8 and Note 9 of the unaudited financial statements for recent events, and states the company expects to remain both a Smaller Reporting Company and an Emerging Growth Company for the foreseeable future. The company also states it has elected the extended transition period for new or revised accounting standards under the JOBS Act. The 10-Q describes the company as an early-stage company with no revenue and says revenue will be recognized under ASC 606 once it begins to generate revenue.